CA Retrans Capsule
By CA Retrans
10 Capsule in a Strip

Composition
Tretinoin(20mg)

Manufacturer - AMPS Biotech Pvt Ltd
36/22, Near Annapurna Building, J B Nagar, Andheri East, Mumbai City, Maharashtra, 400069

Expires on or after
July, 2025

liver
Limited information is available on using CA Retrans Capsule in individuals with liver disease, therefore it is important to consult your doctor before taking this medicine. Caution is advised when using this medicine in patients with liver issues to ensure safety and effectiveness.

kidney
Limited information is available on using CA Retrans Capsule in patients with kidney disease. Consult your doctor for proper guidance. Exercise caution when using this medicine in such patients.

alcohol
Consult your doctor when consuming alcohol with CA Retrans Capsule.

driving
CA Retrans Capsule can impair driving ability, particularly if experiencing dizziness or severe headaches. Prioritize safety and avoid driving while on this medication.

pregnancy
CA Retrans Capsule should not be used during pregnancy due to potential risks to the baby. However, in serious situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor for guidance.

breastfeeding
CA Retrans Capsule is considered safe for breastfeeding as per limited human data, indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | Retinoids |
Therapeutic Class | - |
Action Class | Retinoids- First generation |
₹1175
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025